New therapeutic target discovered for Alzheimer's disease
Tuesday, March 18, 2014 - 12:32
in Health & Medicine
A team of scientists report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Abeta peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.